Health Care [ 5/12 ] | Health Care Providers & Services [ 15/74 ]
NYSE | Common Stock
Humana Inc. provides medical and specialty insurance products in the United States.
It operates in two segments, Insurance and CenterWell.
It offers medical care and supplemental benefit plans to individuals.
The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
In addition, it provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; and military services, such as TRICARE T2017 East Region contract.
Further, the company engages in the operation of pharmacy benefit manager business; operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties.
It sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies.
The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974.
Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jan 23, 25 | -2.16 Decreased by -1.86 K% | -2.12 Decreased by -1.93% |
| Oct 30, 24 | 4.16 Decreased by -46.53% | 3.40 Increased by +22.35% |
| Jul 31, 24 | 6.96 Decreased by -22.15% | 5.85 Increased by +18.97% |
| Apr 24, 24 | 7.23 Decreased by -22.92% | 6.12 Increased by +18.14% |
| Jan 25, 24 | -0.11 Decreased by -106.79% | 0.15 Decreased by -173.33% |
| Nov 1, 23 | 7.78 Increased by +13.08% | 7.16 Increased by +8.66% |
| Aug 2, 23 | 8.94 Increased by +3.11% | 8.82 Increased by +1.36% |
| Apr 26, 23 | 9.38 Increased by +16.67% | 9.27 Increased by +1.19% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 29.21 B Increased by +10.40% | -693.00 M Decreased by -28.10% | Decreased by -2.37% Decreased by -16.03% |
| Sep 30, 24 | 29.40 B Increased by +11.26% | 480.00 M Decreased by -42.31% | Increased by +1.63% Decreased by -48.14% |
| Jun 30, 24 | 29.54 B Increased by +10.44% | 679.00 M Decreased by -29.20% | Increased by +2.30% Decreased by -35.89% |
| Mar 31, 24 | 29.61 B Increased by +10.73% | 741.00 M Decreased by -40.19% | Increased by +2.50% Decreased by -45.99% |
| Dec 31, 23 | 26.46 B Increased by +17.93% | -541.00 M Decreased by -3.51 K% | Decreased by -2.04% Decreased by -2.96 K% |
| Sep 30, 23 | 26.42 B Increased by +15.90% | 832.00 M Decreased by -30.26% | Increased by +3.15% Decreased by -39.82% |
| Jun 30, 23 | 26.75 B Increased by +13.04% | 959.00 M Increased by +37.59% | Increased by +3.59% Increased by +21.72% |
| Mar 31, 23 | 26.74 B Increased by +11.56% | 1.24 B Increased by +33.23% | Increased by +4.63% Increased by +19.42% |